JPRN-UMIN000004994已完成1 期
Cancer specific vaccine therapy using HLA-A24 restricted epitope-peptide for patients with advanced metastatic colorectal cancer.PhaseI/II clinical trial. - Cancer peptide vaccine for advanced metastatic cancer.
Hokkaido Cancer Center0 个研究点目标入组 30 人开始时间: 2011年2月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Expectant 2 During lactation 3 possible expectant women 4 Active infectious diseases 5 Systemic use of steroid hormones or immunosuppressive drugs 6 Others (Doctors judges)
研究者
相似试验
已完成
1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000702Institute of Medical Science, University of Tokyo6
已完成
1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000782Institute of Medical Science, University of Tokyo6
已完成
1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from URLC10:a phase I study in patient with unresectable esophageal cancerunresectable esophageal cancerJPRN-UMIN000000955Institute of Medical Science The University of Tokyo6
已完成
不适用
Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000704Institute of Medical Science, University of Tokyo6
已完成
1 期
Cancer vaccine therapy with HLA-A24 restricted epitope peptide cocktail for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.Advanced metastatic colorectal cancersJPRN-UMIN000004959Tokai University School of Medicine30